Unknown PHASE2 INTERVENTIONAL 1-arm NCT02805608

uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Phase II Trial: uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Sponsor: Rigshospitalet, Denmark

Interventions Injection of 18F-FDG Injection of 68Ga-NOTA-AE105 Positron Emission Tomography and CT Positron Emission Tomography and MRI

Updated 7 times since 2017 Last updated: Apr 9, 2018 Started: Sep 30, 2016 Primary completion: Jan 31, 2019 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02805608, this PHASE2 trial focuses on Urinary Bladder Neoplasms and remains ongoing. Sponsored by Rigshospitalet, Denmark, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
May 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Jun 2018 — May 2020 [monthly]

Active Not Recruiting PHASE2

▶ Show 2 earlier versions

May 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Jan 2017 — May 2018 [monthly]

Recruiting PHASE2

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark